ITMCTR2000004006
Recruiting
Phase 1
A multicenter, randomized, controlled study of a novel detoxifying, detoxifying, detoxifying, detoxifying, and regulating vaginal microecology in the treatment of persistent cervical human papillomavirus infection at high risk
Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Cervical high risk human papillomavirus (HPV) infection continues
- Sponsor
- Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •(1\) Between the ages of 18 and 55, married or sexually active women;
- •(2\) Had been infected with HPV virus for more than one year;
- •(3\) After sampling and examination in our hospital, the classification reported the presence of cervical HPV infection status, and the syndrome differentiation of TRADITIONAL Chinese medicine belongs to the wet\-toxin type;
- •(4\) Those who sign the informed consent.
Exclusion Criteria
- •(1\) Liquid base thin layer cytological examination (TCT) of highly squamous intraepithelial lesions and infiltrating carcinoma, or histopathological examination of CINII and above high\-grade lesions;
- •(2\) Vaginal infections during the week prior to enrollment;
- •(3\) Those who were using other drugs to treat HPV infection or immunosuppressive drugs in the first three months before inclusion;
- •(4\) Women during pregnancy and lactation;
- •(5\) people who have mental diseases or diseases of important organs or metabolic diseases of the body;
- •(6\) Persons with infectious diseases, such as tuberculosis, hepatitis B, or venereal diseases;
- •(7\) For bad life habits or recent exposure to toxic substances, such as drugs, X\-rays;
- •(8\) Therefore, other clinical trial investigators are being accepted.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for the treatment of dermatophytic onychomycosis (toenail) without matrix involvement - ONICOEUCTR2009-011125-14-FRPierre Fabre Dermatologie260
Completed
Not Applicable
A multicenter, randomized controlled study of the clinical efficacy of intravenous peramivir versus oseltamivir against influenza A and B virus infection in high-risk patientsInfluenza virus infectionJPRN-UMIN000009479agasaki evaluation organization for clinical interventions120
Completed
Not Applicable
Randomized, multicenter, controlled study for the efficacy of low-protein rice diet in patients with chronic kidney diseaseJPRN-UMIN000015630Department of Clinical Nutrition Science, Niigata University Graduate School of Medical and Dental Sciences100
Recruiting
Not Applicable
RICE study 2JPRN-jRCTs031190063arita Ichiei150
Not yet recruiting
Phase 1
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high riskITMCTR2000003652Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine